# 2026年2月10日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 持续性发作后功能缺失：单纯性 Todd 瘫痪还是非惊厥性癫痫持续状态？

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41661101)
**期刊：** Epilepsia
**PMID：** 41661101
**DOI：** 10.1002/epi.70140

### 第一部分 原文与翻译

**英文原标题：** Prolonged postictal deficit: Uncomplicated Todd's palsy or nonconvulsive status epilepticus?

> **英文摘要：**
> OBJECTIVE: Postictal deficits are a well-recognized phenomenon, yet their mechanisms and predictors remain poorly understood. Distinguishing postictal deficits from recurring nonconvulsive seizures (NCSz) or nonconvulsive status epilepticus (NCSE), their main differential diagnosis, can be challenging. This study aimed to identify clinical and electrographic features predictive of ongoing or recurrent ictal activity and to explore biomarkers associated with the duration and severity of postictal deficits. METHODS: We conducted a retrospective case-control study of patients with prolonged (>1 h) postictal deficits at a tertiary medical center between 2017 and 2022. Based on electroencephalographic (EEG) findings, patients were classified as having uncomplicated Todd's palsy or recurring NCSz. Clinical, imaging, and electrographic characteristics were compared between groups, and factors associated with postictal duration were analyzed. RESULTS: Among 112 patients, 86 (77%) had uncomplicated Todd's palsy and 26 (23%) had recurring NCSz. Patients with NCSz were younger (63 vs. 76 years, p = .022) and had longer deficits (2.5 vs. 1.5 days, p = .024). Sporadic epileptiform discharges (73% vs. 22%, p < .001) and rhythmic or periodic discharges on the ictal-interictal continuum (50% vs. 16%, p = .001) were significantly more frequent in the NCSE group, even when limited to short EEGs or the first 30 min of continuous EEG (96% vs. 40%, p < .001). Consequently, 2HELPS2B scores were higher in NCSE patients (2 vs. 1, p = .0065). In the uncomplicated Todd's palsy group, a preceding focal to bilateral tonic-clonic seizure (1.5 vs. 1.0 days, p = .04) and any rhythmic or periodic discharges on EEG (3.0 vs. 1.5 days, p = .003) were associated with longer deficit duration. SIGNIFICANCE: A notable minority of patients with prolonged postictal deficits have recurring NCSz. In the absence of reliable clinical or imaging predictors, patients with prolonged deficits may benefit from a 30-min EEG followed-when 2HELPS2B score > 1-by extended continuous EEG monitoring.

> **中文摘要：**
> 目的：发作后功能缺失是一种公认的现象，但其机制和预测因素仍知之甚少。将发作后功能缺失与其主要的鉴别诊断——复发性非惊厥性癫痫发作（NCSz）或非惊厥性癫痫持续状态（NCSE）区分开来具有挑战性。本研究旨在确定预测持续或复发性发作活动的临床和脑电图特征，并探讨与发作后功能缺失持续时间和严重程度相关的生物标志物。方法：我们对 2017 年至 2022 年期间在某三级医疗中心出现的持续性（>1 小时）发作后功能缺失患者进行了一项回顾性病例对照研究。根据脑电图（EEG）检查结果，患者被归类为单纯性 Todd 瘫痪或复发性 NCSz。比较了两组之间的临床、影像学和脑电图特征，并分析了与发作后持续时间相关的因素。结果：在 112 名患者中，86 名（77%）患有单纯性 Todd 瘫痪，26 名（23%）患有复发性 NCSz。NCSz 患者年龄较轻（63 岁 vs. 76 岁，p = .022），且功能缺失持续时间更长（2.5 天 vs. 1.5 天，p = .024）。NCSE 组中散发性痫样放电（73% vs. 22%，p < .001）以及发作-发作间期连续体上的节律性或周期性放电（50% vs. 16%，p = .001）的发生频率显著更高，即使仅限于常规短程脑电图或连续脑电图的前 30 分钟（96% vs. 40%，p < .001）。因此，NCSE 患者的 2HELPS2B 评分更高（2 分 vs. 1 分，p = .0065）。在单纯性 Todd 瘫痪组中，此前的局灶性继发双侧强直-阵挛发作（1.5 天 vs. 1.0 天，p = .04）和脑电图上出现的任何节律性或周期性放电（3.0 天 vs. 1.5 天，p = .003）与更长的功能缺失持续时间相关。意义：显著比例的持续性发作后功能缺失患者实际上存在复发性 NCSz。在缺乏可靠临床或影像学预测指标的情况下，持续性功能缺失患者可能受益于 30 分钟的脑电图检查，若 2HELPS2B 评分 > 1，则应进行延长的连续脑电图监测。

### 第二部分 AI 大师评价

本研究通过对持续性发作后功能缺失患者的回顾性分析，揭示了约 23% 的此类病例实际上隐藏着非惊厥性癫痫持续状态（NCSE）。研究发现脑电图中的散发性及节律性/周期性放电是区分单纯 Todd 瘫痪与 NCSE 的核心预测指标，并证实了 2HELPS2B 评分在临床决策中的应用价值。该研究的创新性在于提出了分层脑电图监测策略，为临床精准识别和干预发作后神经功能障碍提供了客观依据，尽管回顾性设计在验证严谨性上存在一定局限性。

---

## 2. 功能性/分离性癫痫发作的主观症状及其诊断价值：系统评价

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41661078)
**期刊：** Epilepsia
**PMID：** 41661078
**DOI：** 10.1002/epi.70143

### 第一部分 原文与翻译

**英文原标题：** Subjective symptoms of functional/dissociative seizures and their diagnostic value: A systematic review.

> **英文摘要：**
> OBJECTIVE: Although subjective symptoms have received less attention than observable manifestations of functional/dissociative seizures (FDS), patient-reported experiences provide important insights for diagnosis and management. This systematic review summarizes and synthesizes studies describing the subjective symptomatology of FDS and narratively discusses their potential diagnostic value.
> 
> METHODS: MEDLINE, PsycINFO, and CINAHL were searched from January 1990 to May 2025 for studies reporting qualitative or quantitative data on FDS symptoms. The review was registered in International Prospective Register of Systematic Reviews (PROSPERO; CRD420251008332) and reported in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines. Study quality was assessed using Critical Appraisal Skills Programme (CASP) tools. Data were extracted on study design, sample characteristics, data acquisition method, and reported symptoms. Qualitative data were analyzed thematically following Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ) principles, whereas quantitative findings were synthesized narratively within the same thematic framework.
> 
> RESULTS: Forty-seven studies were included. Subjective symptoms of FDS were highly variable both within and between individuals. Across studies, six broad symptom domains were identified: sensory/pain, arousal, emotional, consciousness-related, cognitive, and motor symptoms. Sensory symptoms (particularly pain and headache), arousal-related symptoms (especially hyperarousal), and emotional symptoms (especially panic and anxiety) were most frequently reported across studies. Symptoms related to altered awareness and dissociation between awareness and responsiveness were described in a smaller number of studies but were more consistently reported as differentiating FDS from epileptic seizures. In contrast, the differential diagnostic value of other subjective symptoms was limited by lack of specificity and insufficient detail regarding context, mode of onset, spread, duration and quality.
> 
> SIGNIFICANCE: Subjective symptoms in FDS are diverse, but common themes emerge. Detailed descriptions are required to extract differential diagnostic value from subjective FDS symptoms. Future studies should collect structured information about FDS symptoms and study them using systematic, multimodal, and cross-cultural approaches.

> **中文摘要：**
> 目的：尽管主观症状受到的关注少于功能性/分离性癫痫发作（FDS）的可观察表现，但患者报告的体验为诊断和管理提供了重要见解。本系统评价总结并整合了描述 FDS 主观症状学的研究，并叙述性地讨论了它们的潜在诊断价值。
> 
> 方法：检索了 MEDLINE、PsycINFO 和 CINAHL 数据库中 1990 年 1 月至 2025 年 5 月期间报告 FDS 症状定性或定量数据的研究。该综述已在国际系统评价前瞻性注册库（PROSPERO；CRD420251008332）注册，并按照系统评价和元分析首选报告项目（PRISMA）2020 指南进行报告。使用关键评估技能计划（CASP）工具评估研究质量。提取了关于研究设计、样本特征、数据采集方法和报告症状的数据。根据加强定性研究综合报告透明度（ENTREQ）原则对定性数据进行主题分析，而在同一主题框架内对定量结果进行叙述性合成。
> 
> 结果：共纳入 47 项研究。FDS 的主观症状在个体内部和个体之间都具有高度变异性。在各项研究中，确定了六个广泛的症状领域：感觉/疼痛、唤醒、情绪、意识相关、认知和运动症状。感觉症状（特别是疼痛和头痛）、唤醒相关症状（特别是高唤醒状态）和情绪症状（特别是惊恐和焦虑）在各项研究中报告最为频繁。涉及意识改变以及意识与反应性之间分离的症状在较少的研究中被描述，但更一致地被报告为区分 FDS 与癫痫发作的特征。相比之下，其他主观症状的鉴别诊断价值受到缺乏特异性以及关于背景、发病模式、扩散、持续时间和性质的细节不足的限制。
> 
> 意义：FDS 的主观症状多种多样，但存在共同的主题。需要详细的描述才能从主观 FDS 症状中提取鉴别诊断价值。未来的研究应收集有关 FDS 症状的结构化信息，并采用系统、多模式和跨文化的方法进行研究。

### 第二部分 AI 大师评价

该系统评价通过对47项研究的深度整合，首次系统性地识别出功能性/分离性癫痫发作（FDS）的六大主观症状领域。研究揭示了意识改变与反应性分离在区分FDS与癫痫中的高诊断价值，同时也指出了感觉和情绪症状因缺乏特异性而在鉴别诊断中的局限。该评价强调了未来临床研究需从零散的症状描述向结构化、多模式的评估转变，为提升功能性癫痫的精准诊断提供了重要的循证依据。

---

## 3. Twinkle 相关疾病的临床与基因型谱：一项跨国队列研究的启示

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41538773)
**期刊：** Neurology
**PMID：** 41538773
**DOI：** 10.1212/WNL.0000000000214401

### 第一部分 原文与翻译

**英文原标题：** Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.

> **英文摘要：**
> BACKGROUND AND OBJECTIVES: Twinkle, encoded by the  gene, is a mitochondrial DNA helicase that unwinds the double helix of DNA during replication, playing a pivotal role in mitochondrial function. Twinkle-related disorders encompass a variety of genetic disorders characterized by mitochondrial dysfunction. Although several phenotypes have been described, the full clinical and molecular spectrum remains poorly defined. The aim of this study was to characterize the phenotypic and genotypic variability among multinational patients diagnosed with Twinkle-related disorders.
> 
> METHODS: A retrospective cohort study was conducted in patients with Twinkle-related disorders at several specialized centers in Italy, France, Germany, Spain, Denmark, Hungary, and the United States, establishing the Twinkle-Related Disorders International Consortium for Trial Readiness (TReDIC). Data were collected from medical records, including clinical features, age at onset, disease progression, and results from genetic testing. Phenotypic categories included infantile-onset cerebellar ataxia, parkinsonism, primary mitochondrial myopathy (PMM), multisystem involvement, asymptomatic carriers, undetermined phenotypes, and other phenotypes. All patients' diagnoses were confirmed by genetic analysis, and their genetic variants were noted. Outcomes included prevalence of phenotypes, symptom chronology, and mutational patterns.
> 
> RESULTS: The study included a total of 189 patients (116 female), with a mean age at symptom onset of 40.3 years. At the time of analysis, 70.4% were alive. PMM was the predominant syndrome (85.2%), and most common features were progressive external ophthalmoplegia (84.7%) and skeletal myopathy (55.6%), followed by hearing loss (17.5%) and psychiatric symptoms (15.3%). Most patients (76.8%) presented with neuromuscular symptoms, with fewer showing CNS (19.6%) or multiorgan (3.6%) features at onset; by more than 8 years from onset, these proportions shifted to 54.4%, 23.3%, and 23.3%, respectively. A total of 73  variants (16 novel) were found, mostly missense, clustered in functionally critical regions.
> 
> DISCUSSION: This large multinational cohort analysis advances our understanding of Twinkle-related disorders by identifying mutational hotspots with clinical relevance and illustrating the broad phenotypic spectrum and progression patterns. In the context of such rare diseases, the formation of international collaborations, such as TReDIC, can enhance our understanding and support the design of upcoming clinical trials.

> **中文摘要：**
> 背景与目的：由该基因编码的 Twinkle 是一种线粒体 DNA 解旋酶，在复制过程中解开 DNA 双螺旋，在线粒体功能中发挥关键作用。Twinkle 相关疾病涵盖了以线粒体功能障碍为特征的多种遗传性疾病。尽管已经描述了多种表型，但完整的临床和分子谱系仍未得到充分界定。本研究旨在表征诊断为 Twinkle 相关疾病的跨国患者的表型和基因型变异性。
> 
> 方法：在意大利、法国、德国、西班牙、丹麦、匈牙利和美国的几家专业中心对 Twinkle 相关疾病患者进行了一项回顾性队列研究，成立了 Twinkle 相关疾病国际试验准备联盟 (TReDIC)。从病历中收集数据，包括临床特征、发病年龄、疾病进展和基因检测结果。表型分类包括婴儿期起病的小脑性共济失调、帕金森综合征、原发性线粒体肌病 (PMM)、多系统受累、无症状携带者、未确定表型和其他表型。所有患者的诊断均通过基因分析确认，并记录了其遗传变异。结局指标包括表型患病率、症状发生的时间顺序和突变模式。
> 
> 结果：该研究共纳入 189 例患者（116 例女性），平均发病年龄为 40.3 岁。截至分析时，70.4% 的患者存活。PMM 是最主要的综合征（85.2%），最常见的特征是进行性眼外肌麻痹（84.7%）和骨骼肌病（55.6%），其次是听力下降（17.5%）和精神症状（15.3%）。大多数患者（76.8%）起病时表现为神经肌肉症状，少数表现为中枢神经系统（19.6%）或多器官（3.6%）特征；发病 8 年后，这些比例分别转变为 54.4%、23.3% 和 23.3%。共发现 73 个变异（16 个为新变异），多为错义突变，集中在功能关键区域。
> 
> 讨论：这项大型跨国队列分析通过识别具有临床相关性的突变热点并阐明广泛的表型谱和进展模式，增进了我们对 Twinkle 相关疾病的理解。在这一类罕见病的背景下，建立如 TReDIC 这样的国际合作组织可以加深我们的理解，并为即将进行的临床试验设计提供支持。

### 第二部分 AI 大师评价

这项研究通过建立 TReDIC 国际联盟，对 189 例 Twinkle 相关疾病患者进行了迄今为止最大规模的跨国队列分析，详尽描绘了该病的临床与基因型全景。研究明确了原发性线粒体肌病（PMM）及其核心症状（如眼外肌麻痹）的主导地位，并揭示了症状随病程延长从单纯神经肌肉受累向多器官受累演变的动态过程。通过识别 16 个新变异及突变热点，研究为精准诊断和临床分型提供了关键证据。尽管回顾性设计存在局限性，但该研究建立的国际协作模式为未来针对此类罕见病的临床试验设计奠定了坚实基础。

---

## 4. 转录因子结合与丙戊酸致畸性的个体遗传风险

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41534013)
**期刊：** Neurology
**PMID：** 41534013
**DOI：** 10.1212/WNL.0000000000214570

### 第一部分 原文与翻译

**英文原标题：** Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

> **英文摘要：**
> BACKGROUND AND OBJECTIVES: Valproate (VPA) use during pregnancy is associated with a wide range of structural birth defects, but not all exposed children are affected and there is evidence for a genetic predisposition. The development of a pharmacogenomic biomarker test that can be used for preconception counseling, allowing access to women unnecessarily denied VPA treatment because of concern about teratogenic risks if they were to become pregnant, is challenged by a poor understanding of how variation in maternal DNA could modify the risk. We hypothesized that genomic variants that affect the binding affinity of transcription factors (TFs), key regulators of gene expression, are integral to VPA-associated teratogenicity and a plausible explanation for both variance in interindividual risk and the wide range of birth defect types.
> 
> METHODS: We interrogated genomic variants within maternal exomes from women recruited through international epilepsy pregnancy registries and genomics consortia. We applied a network-based approach that contextualized the variant spectra to genes associated with diverse birth defect types, gene burden tests, and evidence from multiple modalities to identify variant-sensitive TFs.
> 
> RESULTS: Sixty-six pregnancies were exposed to VPA as monotherapy or polytherapy, leading to 28 cases with birth defects, and 184 were exposed to other antiseizure medications (ASMs), leading to 20 cases with birth defects. The variant burden within genes associated with 32 different birth defect types was higher for those exposed to VPA compared with those exposed to other ASMs (OR 1.73 [95% CI 1.39 to 2.13], < 0.0001). Variants in a network comprising significant genes from VPA-exposed mothers were predicted to modify the binding affinity of 359 TFs. These variant-sensitive TFs formed a highly connected protein-protein interaction network, among which the acetyltransferase connected to 41% (147/359) of all proteins. Profiling of coexpression between and other TFs in an embryonic stem cell (hESC) model showed that VPA exposure alters -TF interactions.
> 
> DISCUSSION: These findings suggest that VPA-induced disruption of related gene regulation is a teratogenic mechanism that is common to heterogeneous birth defect types and sensitive to genetic variation. This has implications for the development of pharmacogenomic risk biomarkers and safer drugs for women of childbearing potential.

> **中文摘要：**
> 背景与目的：妊娠期使用丙戊酸（VPA）与多种结构性出生缺陷相关，但并非所有暴露儿童都会受累，且有证据表明存在遗传易感性。开发可用于孕前咨询的药物基因组生物标志物检测，使那些因担心致畸风险而本不该被剥夺 VPA 治疗机会的育龄女性获益，目前正面临着对母体 DNA 变异如何调节风险理解不足的挑战。我们假设，影响转录因子（TFs，基因表达的关键调节因子）结合亲和力的基因组变异是 VPA 相关致畸性的核心，也是个体间风险差异及出生缺陷类型广泛的合理解释。
> 
> 方法：我们分析了通过国际癫痫妊娠登记库和基因组学联盟招募的女性母体外显子组中的基因组变异。我们采用了一种基于网络的方法，将变异谱与多种出生缺陷类型相关的基因、基因负荷测试以及多模态证据相结合，以识别变异敏感型 TF。
> 
> 结果：66 例妊娠暴露于 VPA 单药或多药治疗，导致 28 例出生缺陷；184 例暴露于其他抗癫痫药物（ASMs），导致 20 例出生缺陷。与暴露于其他 ASMs 的患者相比，暴露于 VPA 的患者在与 32 种不同出生缺陷类型相关的基因中的变异负荷更高（OR 1.73 [95% CI 1.39 至 2.13], p < 0.0001）。由 VPA 暴露母亲显著基因组成的网络中的变异预计会改变 359 个 TF 的结合亲和力。这些变异敏感型 TF 形成了一个高度连接的蛋白质-蛋白质相互作用网络，其中乙酰转移酶（EP300）与 41% (147/359) 的蛋白质相连。人类胚胎干细胞（hESC）模型中 EP300 与其他 TF 的共表达分析显示，VPA 暴露改变了 EP300 与 TF 间的相互作用。
> 
> 讨论：这些发现表明，VPA 诱导的 EP300 相关基因调节紊乱是一种通用于异质性出生缺陷类型且对遗传变异敏感的致畸机制。这对于开发药物基因组风险生物标志物以及为育龄女性研制更安全的药物具有重要意义。

### 第二部分 AI 大师评价

本研究通过整合国际癫痫妊娠队列的母体外显子组数据，首次系统揭示了丙戊酸（VPA）致畸性的遗传敏感机制。研究创新性地提出 VPA 通过干扰以 EP300 为核心的转录因子网络结合亲和力，解释了其导致多样化出生缺陷的分子基础。该发现不仅在药理学上明确了 VPA 干扰基因表达调控的普适性机制，也为临床开发预测性生物标志物以评估个体致畸风险提供了关键的分子靶点，具有极高的临床转化价值。

---

## 5. 迟发性不明原因癫痫的大脑结构变化与认知-临床特征

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41512209)
**期刊：** Neurology
**PMID：** 41512209
**DOI：** 10.1212/WNL.0000000000214575

### 第一部分 原文与翻译

**英文原标题：** Brain Structural Changes and Cognitive-Clinical Profiles in Late-Onset Unexplained Epilepsy.

> **英文摘要：**
> BACKGROUND AND OBJECTIVES: Epilepsy incidence peaks in childhood and again after age 55. Up to half of individuals with late-onset epilepsy lack an identifiable cause, but previous imaging studies suggest subtle mesiotemporal atrophy. In this study, we aimed to quantify whole-brain cortical and deep gray matter alterations in late-onset unexplained epilepsy (LOUE) and to examine their associations with cognitive and clinical measures. METHODS: We prospectively recruited patients with LOUE through Brigham and Women's Hospital and its affiliated sites and compared them with sociodemographically matched healthy older adults from the Harvard Aging Brain Study. Inclusion criteria for LOUE were at least 1 unexplained seizure after age 55, onset within the past 5 years, and no identifiable cortical lesion on MRI. All participants underwent 3T structural MRI and neuropsychological testing. Cortical thickness and deep gray matter volumes were extracted, and linear models were used to compare patients with LOUE and controls. Correlations were computed between structural alterations and demographic, cognitive, and clinical measures. RESULTS: We included 59 patients with LOUE (mean age 71.2 ± 7.0 years, 49% female) and 53 controls (mean age 70.7 ± 5.2 years, 53% female). Patients with LOUE showed reduced cortical thickness in sensory and mesiotemporal cortices (β = -0.75, 95% CI [-1.14 to -0.37], FDR-corrected p values [pFDR] < 0.05) and reduced deep gray matter volumes in the pallidum and putamen (β = -0.55, 95% CI [-0.93 to -0.17], pFDR < 0.05). These structural reductions correlated with lower performance on a category fluency task (r = 0.31, p = 0.016) and the extended Preclinical Alzheimer's Cognitive Composite (r = 0.37, p = 0.0041). Conversely, patients showed increased thickness in the left inferior frontal gyrus (β = 0.82, 95% CI [0.43-1.20], pFDR < 0.05) and increased thalamic volume (β = 1.13, 95% CI [0.73-1.53], pFDR < 0.05), which were more pronounced in those with focal seizures sparing consciousness (β = -0.62, p = 0.021). DISCUSSION: Structural brain changes in LOUE are more extensive than previously recognized and are associated with cognitive vulnerability. Although the cross-sectional design and use of independent cohorts limit conclusions about disease progression, the findings suggest that LOUE may fall along a continuum between epilepsy and neurodegenerative disease.

> **中文摘要：**
> 【背景和目标】癫痫的发病率在儿童期以及55岁以后出现两个高峰。多达一半的迟发性癫痫患者缺乏明确的病因，但以往的影像学研究提示存在细微的近中颞叶萎缩。在本研究中，我们旨在量化迟发性不明原因癫痫（LOUE）患者全脑皮质和深层灰质的改变，并探讨其与认知及临床指标的相关性。【方法】我们通过布莱根妇女医院及其附属机构前瞻性招募了LOUE患者，并将其与来自哈佛老化大脑研究的社会人口学匹配的健康老年人进行比较。LOUE的纳入标准为：55岁后至少发生过1次不明原因的癫痫发作，发病时间在过去5年内，且MRI未发现可识别的皮质病变。所有受试者均接受了3T结构MRI扫描和神经心理学测试。提取了皮质厚度和深层灰质体积，并使用线性模型比较LOUE患者与对照组。计算了结构改变与人口学、认知及临床指标之间的相关性。【结果】我们共纳入59名LOUE患者（平均年龄71.2 ± 7.0岁，49%为女性）和53名对照者（平均年龄70.7 ± 5.2岁，53%为女性）。LOUE患者的感觉皮质和近中颞叶皮质厚度减少（β = -0.75, 95% CI [-1.14至-0.37]，FDR校正后的p值 [pFDR] < 0.05），苍白球和壳核的深层灰质体积减少（β = -0.55, 95% CI [-0.93至-0.17], pFDR < 0.05）。这些结构萎缩与类别流畅性任务（r = 0.31, p = 0.016）和扩展版临床前阿尔茨海默病认知综合征（r = 0.37, p = 0.0041）的较差表现相关。相反，患者表现出左下额回厚度增加（β = 0.82, 95% CI [0.43-1.20], pFDR < 0.05）和丘脑体积增加（β = 1.13, 95% CI [0.73-1.53], pFDR < 0.05），这在意识保留的局灶性发作者中更为明显（β = -0.62, p = 0.021）。【讨论】LOUE患者的大脑结构变化比既往认知的更为广泛，且与认知脆弱性相关。尽管横断面设计和独立队列的使用限制了对疾病进展的推论，但研究结果表明，LOUE可能处于癫痫与神经退行性疾病之间的连续谱系中。

### 第二部分 AI 大师评价

本研究通过高分辨率3T MRI系统地量化了迟发性不明原因癫痫（LOUE）患者的全脑结构改变，发现其不仅存在感觉皮质和近中颞叶的萎缩，还伴有特定区域的代偿性肥大。研究揭示了结构损伤与认知功能减退（特别是执行功能和神经退行性标志物）之间的显著关联，为理解LOUE作为癫痫与神经退行性疾病共同通路的潜在机制提供了重要影像学证据。尽管受限于横断面设计，该发现对于临床早期识别此类患者的认知风险及理解疾病连续谱系具有重要的学术价值。

---

## 6. 探讨儿童髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）中中心静脉征和顺磁性边缘病灶的发生率及结局

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41512208)
**期刊：** Neurology
**PMID：** 41512208
**DOI：** 10.1212/WNL.0000000000214410

### 第一部分 原文与翻译

**英文原标题：** Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.

> **英文摘要：**
> BACKGROUND AND OBJECTIVES: Central vein sign (CVS) is a common feature in multiple sclerosis (MS) lesions, but its frequency in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) varies significantly across studies. Paramagnetic rim lesions (PRLs) are described in MS, but not in MOGAD. Our goals were to evaluate the prevalence of PRLs and CVS in a large multicenter cohort of pediatric MOGAD. We compared CVS frequencies between acute vs remission phases, as well as with longitudinal dynamics of lesion evolution. METHODS: In this longitudinal retrospective multicenter study, clinical MRIs were assessed from pediatric patients with MOGAD, who had (1) ≥1 brain lesion, (2) susceptibility-based imaging (SBI), and (3) follow-up MRI at least 3 months apart. T2-weighted and fluid-attenuated inversion recovery sequences were analyzed for lesion detection and resolution. SBI was used to assess CVS and PRLs following North American Imaging in MS Cooperative criteria. RESULTS: A total of 65 patients and 130 scans were included. A total of 520 lesions were evaluated. The most common reason for lesion exclusion was size (n = 143, large confluent lesions, n = 122, <3 mm, n = 21). CVS was detected in 97 of 327 (29.7%) lesions, with 32 of 65 (49.2%) patients having at least 1 CVS+ lesion. Patients with ≥1 CVS+ lesion (32/65, 49.2%) had a higher number of lesions ( = 0.002) and lesions suitable for CVS analysis ( < 0.001). Of the 31 patients with ≥3 brain lesions, 11 of 31 (35.5%) had >40% CVS+ lesions and 7 (22.5%) had >50% CVS+ lesions. Only 4 patients had ≥6 CVS+ lesions. The proportion of CVS+ lesions was lower in patients who had SBI acquired during an acute attack vs patients scanned during remission (16% vs 33%,  = 0.015). The rate of lesion resolution was higher in CVS- lesions (177/230, 76%) compared with CVS+ (42/97, 42%,  < 0.001). No PRLs were identified. DISCUSSION: Lesion pathobiology in MOGAD is heterogeneous. CVS identified persistent rather than transient lesions, with resolution more common among CVS- lesions. The high frequency of confluent or multivein lesions limited the proportion suitable for CVS analysis. MRI timing influenced CVS detection, which was higher in remission, suggesting that time of acquisition contributes to variability across MOGAD studies. No PRLs were found, supporting their potential as biomarkers distinguishing MOGAD from MS.

> **中文摘要：**
> 背景与目标：中心静脉征（CVS）是多发性硬化（MS）病灶的常见特征，但在髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）中的发生率在不同研究间差异显著。顺磁性边缘病灶（PRLs）在MS中已有描述，但在MOGAD中未见报道。我们的目标是在一个大型多中心儿科MOGAD队列中评估PRLs和CVS的患病率。我们比较了急性期与缓解期的CVS频率，以及病灶演变的纵向动态过程。方法：在这项纵向回顾性多中心研究中，评估了符合以下条件的儿科MOGAD患者的临床MRI：（1）具有≥1个脑部病灶，（2）进行了敏感性加权成像（SBI），以及（3）随访MRI间隔至少3个月。分析了T2加权和液体衰减反转恢复序列以检测病灶及观察其消退情况。采用SBI，根据北美多发性硬化成像协作组标准评估CVS和PRLs。结果：共纳入65名患者和130次扫描。共评估了520个病灶。排除病灶最常见的原因是病灶大小（n = 143，其中巨大融合性病灶122个，病灶<3 mm者21个）。在327个病灶中检出97个（29.7%）CVS+病灶，65名患者中有32名（49.2%）至少拥有1个CVS+病灶。具有≥1个CVS+病灶的患者（32/65, 49.2%）具有更多的病灶总数（p = 0.002）和更多适合进行CVS分析的病灶（p < 0.001）。在具有≥3个脑部病灶的31名患者中，11名（35.5%）的CVS+病灶比例超过40%，7名（22.5%）的比例超过50%。仅4名患者具有≥6个CVS+病灶。与缓解期扫描的患者相比，在急性发作期进行SBI采集的患者其CVS+病灶比例较低（16% vs 33%, p = 0.015）。与CVS+病灶（42/97, 42%）相比，CVS-病灶的消退率更高（177/230, 76%, p < 0.001）。未发现PRLs。讨论：MOGAD中的病灶病理生理学具有异质性。CVS识别的是持久性病灶而非一过性病灶，消退在CVS-病灶中更为常见。融合性或多静脉病灶的高发生率限制了适合CVS分析的病灶比例。MRI采集时机影响CVS的检出，缓解期的检出率更高，这表明采集时间是导致不同MOGAD研究间结果变异的原因之一。未发现PRLs，这支持了其作为区分MOGAD与MS的潜在生物标志物的价值。

### 第二部分 AI 大师评价

本项多中心纵向研究深入探讨了儿科MOGAD患者的特异性影像学标志物。研究核心发现CVS在MOGAD中主要对应持久性病灶，且其检出率显著受MRI扫描时机（缓解期高于急性期）的影响。最关键的发现是该队列中PRLs的完全缺失，这有力地支持了PRLs作为鉴别MOGAD与多发性硬化的关键特异性生物标志物。尽管存在病灶融合导致的分析受限，该研究仍为MOGAD的鉴别诊断和预后评估提供了重要的循证依据。

---

速递结束，祝您工作愉快！